Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 20 studies | 39% ± 12% | |
lung | 17 studies | 37% ± 12% | |
intestine | 9 studies | 27% ± 10% | |
brain | 7 studies | 24% ± 7% | |
kidney | 6 studies | 28% ± 7% | |
liver | 6 studies | 30% ± 19% | |
eye | 5 studies | 25% ± 6% | |
bone marrow | 5 studies | 35% ± 11% | |
lymph node | 5 studies | 30% ± 12% | |
pancreas | 4 studies | 39% ± 10% | |
placenta | 4 studies | 49% ± 19% | |
uterus | 4 studies | 35% ± 22% | |
breast | 4 studies | 22% ± 3% | |
prostate | 3 studies | 35% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 20791.82 | 653 / 653 | 100% | 143.20 | 603 / 605 |
intestine | 100% | 11449.39 | 965 / 966 | 99% | 147.42 | 524 / 527 |
lung | 100% | 16937.86 | 576 / 578 | 100% | 172.24 | 1151 / 1155 |
uterus | 100% | 7393.27 | 170 / 170 | 99% | 126.72 | 455 / 459 |
skin | 99% | 11129.07 | 1795 / 1809 | 100% | 162.96 | 471 / 472 |
pancreas | 100% | 15354.52 | 328 / 328 | 99% | 83.78 | 176 / 178 |
bladder | 100% | 21169.95 | 21 / 21 | 99% | 155.69 | 497 / 504 |
ovary | 100% | 11556.27 | 180 / 180 | 99% | 78.40 | 424 / 430 |
breast | 100% | 12334.89 | 459 / 459 | 99% | 82.14 | 1102 / 1118 |
esophagus | 100% | 18053.46 | 1444 / 1445 | 98% | 116.82 | 180 / 183 |
prostate | 99% | 8610.11 | 243 / 245 | 99% | 73.58 | 495 / 502 |
brain | 98% | 8388.57 | 2580 / 2642 | 100% | 82.41 | 705 / 705 |
stomach | 98% | 9855.06 | 352 / 359 | 99% | 123.85 | 284 / 286 |
kidney | 100% | 10426.17 | 89 / 89 | 93% | 66.70 | 842 / 901 |
adrenal gland | 100% | 16246.79 | 258 / 258 | 92% | 60.29 | 212 / 230 |
liver | 75% | 5210.62 | 170 / 226 | 89% | 90.61 | 361 / 406 |
adipose | 100% | 14513.57 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 184.68 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 135.01 | 29 / 29 |
peripheral blood | 100% | 56266.97 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 17547.40 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 122.87 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 41.36 | 1 / 1 |
blood vessel | 99% | 8477.16 | 1328 / 1335 | 0% | 0 | 0 / 0 |
heart | 54% | 2315.14 | 468 / 861 | 0% | 0 | 0 / 0 |
muscle | 10% | 377.97 | 84 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006098 | Biological process | pentose-phosphate shunt |
GO_0046166 | Biological process | glyceraldehyde-3-phosphate biosynthetic process |
GO_0009052 | Biological process | pentose-phosphate shunt, non-oxidative branch |
GO_0040008 | Biological process | regulation of growth |
GO_1901159 | Biological process | xylulose 5-phosphate biosynthetic process |
GO_0070062 | Cellular component | extracellular exosome |
GO_0016604 | Cellular component | nuclear body |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005777 | Cellular component | peroxisome |
GO_0031982 | Cellular component | vesicle |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0030976 | Molecular function | thiamine pyrophosphate binding |
GO_0004802 | Molecular function | transketolase activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0000287 | Molecular function | magnesium ion binding |
Gene name | TKT |
Protein name | Transketolase Transketolase isoform 3 Transketolase (EC 2.2.1.1) Transketolase (TK) (EC 2.2.1.1) transketolase (EC 2.2.1.1) |
Synonyms | HEL107 |
Description | FUNCTION: Catalyzes the transfer of a two-carbon ketol group from a ketose donor to an aldose acceptor, via a covalent intermediate with the cofactor thiamine pyrophosphate. . FUNCTION: Catalyzes the transfer of a two-carbon ketol group from a ketose donor to an aldose acceptor, via a covalent intermediate with the cofactor thiamine pyrophosphate. . FUNCTION: Catalyzes the transfer of a two-carbon ketol group from a ketose donor to an aldose acceptor, via a covalent intermediate with the cofactor thiamine pyrophosphate. . FUNCTION: Catalyzes the transfer of a two-carbon ketol group from a ketose donor to an aldose acceptor, via a covalent intermediate with the cofactor thiamine pyrophosphate. . FUNCTION: Catalyzes the transfer of a two-carbon ketol group from a ketose donor to an aldose acceptor, via a covalent intermediate with the cofactor thiamine pyrophosphate. . |
Accessions | F8WAX4 P29401 A0A0S2Z4T2 E9PFF2 ENST00000423525.6 [P29401-1] V9HWD9 ENST00000469678.1 ENST00000462138.6 [P29401-1] ENST00000450814.6 ENST00000423516.5 [P29401-2] F8W888 ENST00000472528.5 A0A0S2Z5C0 |